<DOC>
	<DOCNO>NCT00156325</DOCNO>
	<brief_summary>This study investigate efficacy Escitalopram , Selective Serotonin Reuptake Inhibitor ( SSRI ) antidepressant , treatment Bipolar II Disorder . The use antidepressant bipolar disorder appear common clinical practice countenance - least monotherapy - formal treatment guideline . This view reflect concern possibility antidepressant drug induce switch rapid cycling Bipolar Disorder . Although effectiveness treat Bipolar II patient SSRIs receive little attention literature , observation Bipolar II patient treat SSRIs suggest may general mood stabilise property . Many patient report improvement depressed mood , also reduction severity , duration frequency hypomanic episode . In proof concept study specifically assess whether standard dose SSRI antidepressant effective placebo reduce frequency , severity duration depressive hypomanic episode .</brief_summary>
	<brief_title>Escitalopram Mood Stabilizer Bipolar II Disorder</brief_title>
	<detailed_description>This study randomize , double-blind , placebo-controlled , cross-over trial Escitalopram ( 10 mg ) versus placebo ( identical presentation ) subject identify Bipolar II Disorder . The nine-month study commence no-treatment baseline period three month ( Baseline Phase ) ensure subject meet criterion episode frequency . Subjects compliant complete baseline period requirement randomize receive Escitalopram placebo three month ( Phase 2 ) subsequently cross receive alternative compound final three-month period ( Phase 3 ) . Prior cross-over , two-day taper period avoid potential withdrawal effect , follow seven-day wash-out period avoid carry-over effect drug placebo . Subjects assess start study , every month thereafter entire nine-month period . Subjects age 18-65 meeting diagnostic criterion Bipolar II disorder recruit . Diagnosis base Diagnostic Statistical Manual Mental Disorders exception minimum four-day duration criterion hypomanic episode . Subjects must minimum 2-year history depressive hypomanic episode , mood disturbance ( either ‘ high ’ ‘ low ’ ) occur least monthly . Subjects exclude previously treat anti-depressants mood-stabilisers , history psychotic symptom episode either hypomania depression . Subjects actively suicidal , significant personality disorder , substantive illicit drug use , alcohol consumption &gt; 30g/day also exclude . Exclusion also apply subject pregnant breastfeeding , history heart disease , liver disease , epilepsy seizure . Subjects complete number self-report questionnaire mood function monthly basis well monitoring mood daily basis . A research psychologist psychiatrist complete ( monthly interval ) Hamilton Depression Rating , Young Mania Rating Scale DSM-IV Social Occupational Functioning Assessment Scale base function previous week throughout nine-month duration study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Aged 1865 Minimum two year history depressive hypomanic episode Mood episode occur monthly Meet DSMIV criterion Bipolar II Disorder ( exception minimum 4 day period hypomanic episode ) Previous treatment antidepressant , mood stabilizer neuroleptic medication History psychotic symptom hypomanic depressive episode Current suicidal behaviour Current substantive illicit drug use alcohol consumption Significant personality disorder Pregnancy breastfeed History heart disease , liver disease , epilepsy seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Hypomania</keyword>
	<keyword>Mood Stabilizer</keyword>
</DOC>